<DOC>
	<DOCNO>NCT00165581</DOCNO>
	<brief_summary>The purpose study understand side effect ( skin reaction , infection abscess formation ) site radiation treatment , occur treatment follow 2 month use new method radiation therapy breast cancer .</brief_summary>
	<brief_title>High Dose Rate Intracavitary Brachytherapy Sole Method Radiation Therapy Breast Carcinoma</brief_title>
	<detailed_description>- Radiation treatment deliver outpatient setting , twice day 5 consecutive treatment day . There minimum 6-hour interval two daily treatment . The applicator simple tube inflatable balloon one end , channel middle tube treatment , two adapter end . - Following surgical removal breast cancer , radiation oncologist assistance surgeon radiologist place applicator surgical cavity . A small radioactive source , iridium-192 , inserted applicator special machine final treatment , applicator remove . - The following procedure do patient radiation therapy : post-partial mastectomy mammogram micro-calcifications confirm complete removal ; CT scan radiation treatment planning ; monitor skin side effect ; photograph breast prior surgery , prior placement applicator 60 day radiation treatment evaluate cosmetic outcome treatment . - Participation study last approximately 2 month completion radiation treatment .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>AJCC stage I II histologically confirm invasive ductal carcinoma breast lesion &lt; = 3cm , treat partial mastectomy 45 year age older Negative ink pathologic specimen &gt; = 3mm margin partial mastectomy reexcision specimen confirm prior introducing radiation source Negative postpartial mastectomy post reexcision mammography cancer present malignancyassociated microcalcifications ; remain suspicious microcalcifications breast brachytherapy Invasive ductal , medullary , papillary , colloid , tubular histology Time interval final definitive breast surgical procedure brachytherapy treatment le 8 week Distant metastasis Invasive lobular carcinoma pure ductal carcinoma situ nonepithelial breast malignancy sarcoma lymphoma Proven multifocal , multicentric carcinoma clinically radiologically suspicious area ipsilateral breast unless confirm negative malignancy biopsy Pregnant lactating Confirmed positive axillary node ipsilateral axilla . Palpable radiographically suspicious contralateral axillary , supraclavicular , infraclavicular , internal mammary node , unless histologic confirmation node negative tumor Prior nonhormonal therapy present breast cancer , include radiation therapy chemotherapy Collagen vascular disease , specifically systemic lupus erythematosis , scleroderma , keloid , ataxia , telangiectasia , dermatomyositis Coexisting medical condition life expectancy &lt; 2 year Psychiatric addictive disorder Paget 's disease nipple Skin involvement regardless size Breast unsatisfactory brachytherapy Surgical margin microscopically assess positive pathological evaluation Extensive intraductal carcinoma Any previously treat contralateral breast carcinoma synchronous bilateral breast carcinoma Other malignancy , except nonmelanoma skin cancer , &lt; 5 year prior participation study Diffuse suspicious microcalcifications</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Intracavitary brachytherapy</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>Stage I breast cancer</keyword>
	<keyword>Stage II breast cancer</keyword>
</DOC>